Dexmedetomidine Promoted HSPB8 Expression via Inhibiting the lncRNA SNHG14/UPF1 Axis to Inhibit Apoptosis of Nerve Cells in AD: The Role of Dexmedetomidine in AD
Dexmedetomidine (Dex) is reported to play a neuroprotective role in Alzheimer’s disease (AD). However, the specific mechanism remains unclear. Figure out the underlying molecular mechanism of Dex regulating nerve cell apoptosis in the AD model. The AD model in vitro was established after SH-SY5Y cel...
Gespeichert in:
| Veröffentlicht in: | Neurotoxicity research 2023-10, Vol.41 (5), p.471-480 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 480 |
|---|---|
| container_issue | 5 |
| container_start_page | 471 |
| container_title | Neurotoxicity research |
| container_volume | 41 |
| creator | Tan, QingYun Liu, LiLi Wang, Shuo Wang, QingDong Sun, Yu |
| description | Dexmedetomidine (Dex) is reported to play a neuroprotective role in Alzheimer’s disease (AD). However, the specific mechanism remains unclear. Figure out the underlying molecular mechanism of Dex regulating nerve cell apoptosis in the AD model. The AD model in vitro was established after SH-SY5Y cells were treated with Aβ1 − 42 at (10 μM) for 24 h. The interaction among UPF1, lncRNA SNHG14, and HSPB8 was verified by RIP assay. Cell viability, apoptosis, the level of genes, and proteins were detected by CCK-8 assay, flow cytometry, Western blot, and qRT-PCR, respectively. Dex downregulated lncRNA SNHG14 level and inhibited apoptosis of nerve cells. LncRNA SNHG14 overexpression reversed the inhibitory effect of Dex on nerve cell apoptosis in the AD model. LncRNA SNHG14 attenuated HSPB8 mRNA stability by recruiting UPF1. HSPB8 overexpression inhibited apoptosis of nerve cells in the AD model. Moreover, HSPB8 knockdown reversed the inhibitory effect of Dex on nerve cell apoptosis in the AD model. Our study demonstrated that Dex promoted HSPB8 expression via inhibiting the lncRNA SNHG14/UPF1 axis to inhibit nerve cell apoptosis in AD. |
| doi_str_mv | 10.1007/s12640-023-00653-4 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2860402420</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2860402420</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1904-a065d6901fc8e6f81230c8ac92d641439974840be3bc523786c2d61088b1b29a3</originalsourceid><addsrcrecordid>eNp9kElPwzAQhSMEEusf4OQjl8B4qeMcQ1mKhErFcrYSZwJGjR3sFJULvx1D4cppRjPvjeZ9WXZM4ZQCFGeRMikgB8ZzADnhudjK9qgoZM4nTGynHliZK8HUbrYf4ysAoxNZ7GWfF7juscXR97a1Dski-N6P2JLZw-Jckcv1EDBG6x15tzW5cS-2saN1z2R8QbJ05n5ekYf57JqKs6fFFSXV2kYy-j8lqQY_jD6moe_IHMM7kikul5FYR6qLw2ynq5cRj37rQfZ0dfk4neW3d9c30-o2N7QEkdcpUytLoJ1RKDtFGQejalOyVgoqeFkWQglokDdmwnihpEkbCko1tGFlzQ-yk83dIfi3FcZR9zaa9Eft0K-iZkqCACYYJCnbSE3wMQbs9BBsX4cPTUF_w9Yb2DrB1j-wtUgmvjHFJHbPGPSrXwWXIv3n-gIhiX-R</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2860402420</pqid></control><display><type>article</type><title>Dexmedetomidine Promoted HSPB8 Expression via Inhibiting the lncRNA SNHG14/UPF1 Axis to Inhibit Apoptosis of Nerve Cells in AD: The Role of Dexmedetomidine in AD</title><source>SpringerLink Journals - AutoHoldings</source><creator>Tan, QingYun ; Liu, LiLi ; Wang, Shuo ; Wang, QingDong ; Sun, Yu</creator><creatorcontrib>Tan, QingYun ; Liu, LiLi ; Wang, Shuo ; Wang, QingDong ; Sun, Yu</creatorcontrib><description>Dexmedetomidine (Dex) is reported to play a neuroprotective role in Alzheimer’s disease (AD). However, the specific mechanism remains unclear. Figure out the underlying molecular mechanism of Dex regulating nerve cell apoptosis in the AD model. The AD model in vitro was established after SH-SY5Y cells were treated with Aβ1 − 42 at (10 μM) for 24 h. The interaction among UPF1, lncRNA SNHG14, and HSPB8 was verified by RIP assay. Cell viability, apoptosis, the level of genes, and proteins were detected by CCK-8 assay, flow cytometry, Western blot, and qRT-PCR, respectively. Dex downregulated lncRNA SNHG14 level and inhibited apoptosis of nerve cells. LncRNA SNHG14 overexpression reversed the inhibitory effect of Dex on nerve cell apoptosis in the AD model. LncRNA SNHG14 attenuated HSPB8 mRNA stability by recruiting UPF1. HSPB8 overexpression inhibited apoptosis of nerve cells in the AD model. Moreover, HSPB8 knockdown reversed the inhibitory effect of Dex on nerve cell apoptosis in the AD model. Our study demonstrated that Dex promoted HSPB8 expression via inhibiting the lncRNA SNHG14/UPF1 axis to inhibit nerve cell apoptosis in AD.</description><identifier>ISSN: 1029-8428</identifier><identifier>ISSN: 1476-3524</identifier><identifier>EISSN: 1476-3524</identifier><identifier>DOI: 10.1007/s12640-023-00653-4</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Biomedical and Life Sciences ; Biomedicine ; Cell Biology ; Neurobiology ; Neurochemistry ; Neurology ; Neurosciences ; Pharmacology/Toxicology</subject><ispartof>Neurotoxicity research, 2023-10, Vol.41 (5), p.471-480</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1904-a065d6901fc8e6f81230c8ac92d641439974840be3bc523786c2d61088b1b29a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12640-023-00653-4$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12640-023-00653-4$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids></links><search><creatorcontrib>Tan, QingYun</creatorcontrib><creatorcontrib>Liu, LiLi</creatorcontrib><creatorcontrib>Wang, Shuo</creatorcontrib><creatorcontrib>Wang, QingDong</creatorcontrib><creatorcontrib>Sun, Yu</creatorcontrib><title>Dexmedetomidine Promoted HSPB8 Expression via Inhibiting the lncRNA SNHG14/UPF1 Axis to Inhibit Apoptosis of Nerve Cells in AD: The Role of Dexmedetomidine in AD</title><title>Neurotoxicity research</title><addtitle>Neurotox Res</addtitle><description>Dexmedetomidine (Dex) is reported to play a neuroprotective role in Alzheimer’s disease (AD). However, the specific mechanism remains unclear. Figure out the underlying molecular mechanism of Dex regulating nerve cell apoptosis in the AD model. The AD model in vitro was established after SH-SY5Y cells were treated with Aβ1 − 42 at (10 μM) for 24 h. The interaction among UPF1, lncRNA SNHG14, and HSPB8 was verified by RIP assay. Cell viability, apoptosis, the level of genes, and proteins were detected by CCK-8 assay, flow cytometry, Western blot, and qRT-PCR, respectively. Dex downregulated lncRNA SNHG14 level and inhibited apoptosis of nerve cells. LncRNA SNHG14 overexpression reversed the inhibitory effect of Dex on nerve cell apoptosis in the AD model. LncRNA SNHG14 attenuated HSPB8 mRNA stability by recruiting UPF1. HSPB8 overexpression inhibited apoptosis of nerve cells in the AD model. Moreover, HSPB8 knockdown reversed the inhibitory effect of Dex on nerve cell apoptosis in the AD model. Our study demonstrated that Dex promoted HSPB8 expression via inhibiting the lncRNA SNHG14/UPF1 axis to inhibit nerve cell apoptosis in AD.</description><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cell Biology</subject><subject>Neurobiology</subject><subject>Neurochemistry</subject><subject>Neurology</subject><subject>Neurosciences</subject><subject>Pharmacology/Toxicology</subject><issn>1029-8428</issn><issn>1476-3524</issn><issn>1476-3524</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kElPwzAQhSMEEusf4OQjl8B4qeMcQ1mKhErFcrYSZwJGjR3sFJULvx1D4cppRjPvjeZ9WXZM4ZQCFGeRMikgB8ZzADnhudjK9qgoZM4nTGynHliZK8HUbrYf4ysAoxNZ7GWfF7juscXR97a1Dski-N6P2JLZw-Jckcv1EDBG6x15tzW5cS-2saN1z2R8QbJ05n5ekYf57JqKs6fFFSXV2kYy-j8lqQY_jD6moe_IHMM7kikul5FYR6qLw2ynq5cRj37rQfZ0dfk4neW3d9c30-o2N7QEkdcpUytLoJ1RKDtFGQejalOyVgoqeFkWQglokDdmwnihpEkbCko1tGFlzQ-yk83dIfi3FcZR9zaa9Eft0K-iZkqCACYYJCnbSE3wMQbs9BBsX4cPTUF_w9Yb2DrB1j-wtUgmvjHFJHbPGPSrXwWXIv3n-gIhiX-R</recordid><startdate>20231001</startdate><enddate>20231001</enddate><creator>Tan, QingYun</creator><creator>Liu, LiLi</creator><creator>Wang, Shuo</creator><creator>Wang, QingDong</creator><creator>Sun, Yu</creator><general>Springer US</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20231001</creationdate><title>Dexmedetomidine Promoted HSPB8 Expression via Inhibiting the lncRNA SNHG14/UPF1 Axis to Inhibit Apoptosis of Nerve Cells in AD</title><author>Tan, QingYun ; Liu, LiLi ; Wang, Shuo ; Wang, QingDong ; Sun, Yu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1904-a065d6901fc8e6f81230c8ac92d641439974840be3bc523786c2d61088b1b29a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cell Biology</topic><topic>Neurobiology</topic><topic>Neurochemistry</topic><topic>Neurology</topic><topic>Neurosciences</topic><topic>Pharmacology/Toxicology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tan, QingYun</creatorcontrib><creatorcontrib>Liu, LiLi</creatorcontrib><creatorcontrib>Wang, Shuo</creatorcontrib><creatorcontrib>Wang, QingDong</creatorcontrib><creatorcontrib>Sun, Yu</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neurotoxicity research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tan, QingYun</au><au>Liu, LiLi</au><au>Wang, Shuo</au><au>Wang, QingDong</au><au>Sun, Yu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dexmedetomidine Promoted HSPB8 Expression via Inhibiting the lncRNA SNHG14/UPF1 Axis to Inhibit Apoptosis of Nerve Cells in AD: The Role of Dexmedetomidine in AD</atitle><jtitle>Neurotoxicity research</jtitle><stitle>Neurotox Res</stitle><date>2023-10-01</date><risdate>2023</risdate><volume>41</volume><issue>5</issue><spage>471</spage><epage>480</epage><pages>471-480</pages><issn>1029-8428</issn><issn>1476-3524</issn><eissn>1476-3524</eissn><abstract>Dexmedetomidine (Dex) is reported to play a neuroprotective role in Alzheimer’s disease (AD). However, the specific mechanism remains unclear. Figure out the underlying molecular mechanism of Dex regulating nerve cell apoptosis in the AD model. The AD model in vitro was established after SH-SY5Y cells were treated with Aβ1 − 42 at (10 μM) for 24 h. The interaction among UPF1, lncRNA SNHG14, and HSPB8 was verified by RIP assay. Cell viability, apoptosis, the level of genes, and proteins were detected by CCK-8 assay, flow cytometry, Western blot, and qRT-PCR, respectively. Dex downregulated lncRNA SNHG14 level and inhibited apoptosis of nerve cells. LncRNA SNHG14 overexpression reversed the inhibitory effect of Dex on nerve cell apoptosis in the AD model. LncRNA SNHG14 attenuated HSPB8 mRNA stability by recruiting UPF1. HSPB8 overexpression inhibited apoptosis of nerve cells in the AD model. Moreover, HSPB8 knockdown reversed the inhibitory effect of Dex on nerve cell apoptosis in the AD model. Our study demonstrated that Dex promoted HSPB8 expression via inhibiting the lncRNA SNHG14/UPF1 axis to inhibit nerve cell apoptosis in AD.</abstract><cop>New York</cop><pub>Springer US</pub><doi>10.1007/s12640-023-00653-4</doi><tpages>10</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1029-8428 |
| ispartof | Neurotoxicity research, 2023-10, Vol.41 (5), p.471-480 |
| issn | 1029-8428 1476-3524 1476-3524 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2860402420 |
| source | SpringerLink Journals - AutoHoldings |
| subjects | Biomedical and Life Sciences Biomedicine Cell Biology Neurobiology Neurochemistry Neurology Neurosciences Pharmacology/Toxicology |
| title | Dexmedetomidine Promoted HSPB8 Expression via Inhibiting the lncRNA SNHG14/UPF1 Axis to Inhibit Apoptosis of Nerve Cells in AD: The Role of Dexmedetomidine in AD |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T04%3A57%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dexmedetomidine%20Promoted%20HSPB8%20Expression%20via%20Inhibiting%20the%20lncRNA%20SNHG14/UPF1%20Axis%20to%20Inhibit%20Apoptosis%20of%20Nerve%20Cells%20in%20AD:%20The%20Role%20of%20Dexmedetomidine%20in%20AD&rft.jtitle=Neurotoxicity%20research&rft.au=Tan,%20QingYun&rft.date=2023-10-01&rft.volume=41&rft.issue=5&rft.spage=471&rft.epage=480&rft.pages=471-480&rft.issn=1029-8428&rft.eissn=1476-3524&rft_id=info:doi/10.1007/s12640-023-00653-4&rft_dat=%3Cproquest_cross%3E2860402420%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2860402420&rft_id=info:pmid/&rfr_iscdi=true |